- Home
- JKHY vs ASND Comparison
JKHY vs ASND Comparison
Compare JKHY & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKHY
- ASND
- Stock Information
- Founded
- JKHY 1976
- ASND 2006
- Country
- JKHY United States
- ASND Denmark
- Employees
- JKHY N/A
- ASND N/A
- Industry
- JKHY Retail: Computer Software & Peripheral Equipment
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- JKHY Technology
- ASND Health Care
- Exchange
- JKHY Nasdaq
- ASND Nasdaq
- Market Cap
- JKHY 12.6B
- ASND 12.0B
- IPO Year
- JKHY N/A
- ASND 2015
- Fundamental
- Price
- JKHY $149.46
- ASND $209.64
- Analyst Decision
- JKHY Hold
- ASND Strong Buy
- Analyst Count
- JKHY 8
- ASND 16
- Target Price
- JKHY $180.88
- ASND $240.75
- AVG Volume (30 Days)
- JKHY 1.2M
- ASND 398.9K
- Earning Date
- JKHY 11-04-2025
- ASND 11-13-2025
- Dividend Yield
- JKHY 1.54%
- ASND N/A
- EPS Growth
- JKHY 19.31
- ASND N/A
- EPS
- JKHY 6.24
- ASND N/A
- Revenue
- JKHY $2,375,288,000.00
- ASND $576,332,355.00
- Revenue This Year
- JKHY $6.98
- ASND $102.31
- Revenue Next Year
- JKHY $6.41
- ASND $76.44
- P/E Ratio
- JKHY $24.13
- ASND N/A
- Revenue Growth
- JKHY 7.21
- ASND 54.50
- 52 Week Low
- JKHY $144.12
- ASND $118.03
- 52 Week High
- JKHY $196.00
- ASND $214.71
- Technical
- Relative Strength Index (RSI)
- JKHY 36.79
- ASND 64.93
- Support Level
- JKHY $144.13
- ASND $187.25
- Resistance Level
- JKHY $151.81
- ASND $214.71
- Average True Range (ATR)
- JKHY 2.64
- ASND 6.34
- MACD
- JKHY 0.15
- ASND 1.37
- Stochastic Oscillator
- JKHY 39.35
- ASND 84.63
About JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.